Novartis
Latest Stories
fda_leukemia_drug_approved_61216.jpg
This image provided by Novartis shows Rydapt. The Food and Drug Administration on Friday approved Rydapt for treating adults newly diagnosed with acute myeloid leukemia who have a genetic mutation called FLT3. Patients would take it along with chemotherapy.The drug, known chemically as midostaurin, is the first new medicine for acute myeloid leukemia in 25 years, according to the company. (Novartis via AP)
breast_cancer_drug_51069.jpg
FILE - In a Saturday, Aug. 13, 2016 file photo, logo of Swiss pharmaceutical company Novartis is seen at the Novartis Korea office in Seoul, South Korea. U.S. regulators have approved a new drug as an initial treatment for postmenopausal women with a type of advanced breast cancer. The drug, called Kisqali, developed by Swiss drugmaker Novartis, is a pill that works to slow the spread of cancer by blocking two proteins that can stimulate growth and division of cancer cells. (AP Photo/Ahn Young-joon, File)
121_2014_ap0001130871-08201.jpg
Switzerland is home to two of the world's biggest pharmaceutical companies, Roche and Novartis, but 65 percent of those two firms' employees are not native-born Swiss. (associated press)
